Hence, the NFKB1 -94ins/delATTG promoter polymorphism seems to be a promising candidate supporting the prediction of CMV infection and enrichment of risk-adapted anti-CMV strategies in terms of precision medicine. Here, NFKB1 is linked to cytomegalovirus infection.